Intraocular pressure reduction with once-a-day application of a new prostaglandin eye drop: a pilot placebo-controlled study in 12 patients

ConclusionsThe travoprost metabolite 15-keto fluprostenol was effective in decrease IOP and maintained IOP reduction along 5 days of treatment. The 15-keto fluprostenol can be developed as a good candidate for once-a-day NTG patients’ treatment.

http://link.springer.com/10.1007/s10792-019-01243-0

Source: International Ophthalmology - December 2, 2019 Category: Opthalmology Source Type: research